Impedimed Long Term Debt vs Intangible Assets Analysis

IPD Stock

0.05 0 1.92%

Impedimed financial indicator trend analysis is infinitely more than just investigating Impedimed recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Impedimed is a good investment. Please check the relationship between Impedimed Long Term Debt and its Intangible Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Long Term Debt vs Intangible Assets

Long Term Debt vs Intangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Impedimed Long Term Debt account and Intangible Assets. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Impedimed's Long Term Debt and Intangible Assets is -0.04. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of Impedimed, assuming nothing else is changed. The correlation between historical values of Impedimed's Long Term Debt and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Impedimed are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Long Term Debt i.e., Impedimed's Long Term Debt and Intangible Assets go up and down completely randomly.

Correlation Coefficient

-0.04

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Long Term Debt

Long-term debt is a debt that Impedimed has held for over one year. Long-term debt appears on Impedimed balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Impedimed balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Most indicators from Impedimed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Impedimed current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Impedimed's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 40.3 K in 2024, whereas Discontinued Operations is likely to drop (120 K) in 2024.

	2021	2022	2023	2024 (projected)
Cost Of Revenue	23.9M	25.0M	1.3M	1.2M
Total Revenue	10.6M	11.3M	10.3M	5.2M

Cost Of Revenue Total Revenue

Impedimed fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Other Liab	Accounts Payable	Other Assets	Long Term Debt	Net Receivables	Good Will	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding
Total Assets		0.0	0.2	0.3	0.6	0.28	-0.41	0.43	0.63	0.1	0.62	0.26	0.28	0.68	0.28	0.12	0.98	0.34	-0.93	-0.46	0.94	0.31	-0.15	0.94	0.66	0.37
Other Current Liab	0.0		0.94	0.05	0.26	0.22	0.63	0.36	0.18	-0.54	0.32	0.89	0.18	0.03	0.0	-0.24	0.09	0.03	-0.07	-0.1	0.07	0.13	-0.06	0.07	0.11	0.11
Total Current Liabilities	0.2	0.94		0.13	0.52	0.4	0.47	0.58	0.4	-0.57	0.51	0.97	0.35	0.27	0.08	-0.31	0.25	0.15	-0.2	-0.31	0.21	0.27	-0.23	0.21	0.34	0.27
Other Liab	0.3	0.05	0.13		0.03	0.66	-0.11	0.61	0.56	-0.47	0.11	0.3	0.91	0.58	0.94	0.27	0.25	0.87	-0.05	-0.79	0.09	0.96	0.35	0.09	0.42	0.95
Accounts Payable	0.6	0.26	0.52	0.03		0.53	-0.26	0.48	0.66	0.06	0.79	0.49	0.22	0.59	0.0	-0.34	0.54	0.03	-0.52	-0.5	0.52	0.2	-0.29	0.52	0.66	0.24
Other Assets	0.28	0.22	0.4	0.66	0.53		-0.31	0.73	0.85	-0.38	0.63	0.5	0.76	0.79	0.65	-0.01	0.15	0.64	0.01	-0.94	0.01	0.77	0.01	0.01	0.76	0.76
Long Term Debt	-0.41	0.63	0.47	-0.11	-0.26	-0.31		-0.22	-0.39	-0.35	-0.34	0.4	-0.04	-0.61	-0.12	-0.1	-0.21	-0.14	0.19	0.42	-0.18	-0.09	0.19	-0.18	-0.6	-0.17
Net Receivables	0.43	0.36	0.58	0.61	0.48	0.73	-0.22		0.71	-0.63	0.51	0.7	0.8	0.83	0.55	-0.16	0.35	0.65	-0.17	-0.82	0.19	0.73	-0.32	0.19	0.77	0.78
Good Will	0.63	0.18	0.4	0.56	0.66	0.85	-0.39	0.71		-0.27	0.72	0.51	0.67	0.89	0.56	0.11	0.53	0.59	-0.38	-0.88	0.4	0.68	-0.1	0.4	0.89	0.67
Inventory	0.1	-0.54	-0.57	-0.47	0.06	-0.38	-0.35	-0.63	-0.27		-0.08	-0.65	-0.65	-0.27	-0.47	0.14	0.09	-0.51	-0.22	0.43	0.2	-0.56	0.02	0.2	-0.22	-0.54
Other Current Assets	0.62	0.32	0.51	0.11	0.79	0.63	-0.34	0.51	0.72	-0.08		0.53	0.23	0.69	0.18	0.02	0.53	0.27	-0.49	-0.59	0.49	0.24	-0.28	0.49	0.8	0.24
Total Liab	0.26	0.89	0.97	0.3	0.49	0.5	0.4	0.7	0.51	-0.65	0.53		0.51	0.41	0.25	-0.16	0.3	0.35	-0.21	-0.44	0.22	0.43	-0.23	0.22	0.44	0.42
Intangible Assets	0.28	0.18	0.35	0.91	0.22	0.76	-0.04	0.8	0.67	-0.65	0.23	0.51		0.67	0.86	0.09	0.23	0.86	-0.01	-0.86	0.05	0.98	0.08	0.05	0.52	0.97
Common Stock	0.68	0.03	0.27	0.58	0.59	0.79	-0.61	0.83	0.89	-0.27	0.69	0.41	0.67		0.56	0.09	0.54	0.62	-0.38	-0.9	0.39	0.67	-0.22	0.39	0.97	0.71
Property Plant Equipment	0.28	0.0	0.08	0.94	0.0	0.65	-0.12	0.55	0.56	-0.47	0.18	0.25	0.86	0.56		0.4	0.23	0.95	-0.04	-0.77	0.08	0.91	0.38	0.08	0.44	0.87
Short Long Term Debt Total	0.12	-0.24	-0.31	0.27	-0.34	-0.01	-0.1	-0.16	0.11	0.14	0.02	-0.16	0.09	0.09	0.4		0.13	0.45	-0.06	-0.04	0.07	0.17	0.11	0.07	0.04	0.03
Total Stockholder Equity	0.98	0.09	0.25	0.25	0.54	0.15	-0.21	0.35	0.53	0.09	0.53	0.3	0.23	0.54	0.23	0.13		0.29	-0.97	-0.33	0.98	0.25	-0.1	0.98	0.53	0.31
Property Plant And Equipment Net	0.34	0.03	0.15	0.87	0.03	0.64	-0.14	0.65	0.59	-0.51	0.27	0.35	0.86	0.62	0.95	0.45	0.29		-0.09	-0.76	0.13	0.88	0.1	0.13	0.49	0.83
Net Debt	-0.93	-0.07	-0.2	-0.05	-0.52	0.01	0.19	-0.17	-0.38	-0.22	-0.49	-0.21	-0.01	-0.38	-0.04	-0.06	-0.97	-0.09		0.15	-1.0	-0.04	0.11	-1.0	-0.4	-0.1
Retained Earnings	-0.46	-0.1	-0.31	-0.79	-0.5	-0.94	0.42	-0.82	-0.88	0.43	-0.59	-0.44	-0.86	-0.9	-0.77	-0.04	-0.33	-0.76	0.15		-0.17	-0.87	-0.01	-0.17	-0.83	-0.89
Cash	0.94	0.07	0.21	0.09	0.52	0.01	-0.18	0.19	0.4	0.2	0.49	0.22	0.05	0.39	0.08	0.07	0.98	0.13	-1.0	-0.17		0.08	-0.09	1.0	0.4	0.14
Non Current Assets Total	0.31	0.13	0.27	0.96	0.2	0.77	-0.09	0.73	0.68	-0.56	0.24	0.43	0.98	0.67	0.91	0.17	0.25	0.88	-0.04	-0.87	0.08		0.21	0.08	0.52	0.98
Non Currrent Assets Other	-0.15	-0.06	-0.23	0.35	-0.29	0.01	0.19	-0.32	-0.1	0.02	-0.28	-0.23	0.08	-0.22	0.38	0.11	-0.1	0.1	0.11	-0.01	-0.09	0.21		-0.09	-0.21	0.19
Cash And Short Term Investments	0.94	0.07	0.21	0.09	0.52	0.01	-0.18	0.19	0.4	0.2	0.49	0.22	0.05	0.39	0.08	0.07	0.98	0.13	-1.0	-0.17	1.0	0.08	-0.09		0.4	0.14
Common Stock Total Equity	0.66	0.11	0.34	0.42	0.66	0.76	-0.6	0.77	0.89	-0.22	0.8	0.44	0.52	0.97	0.44	0.04	0.53	0.49	-0.4	-0.83	0.4	0.52	-0.21	0.4		0.56
Common Stock Shares Outstanding	0.37	0.11	0.27	0.95	0.24	0.76	-0.17	0.78	0.67	-0.54	0.24	0.42	0.97	0.71	0.87	0.03	0.31	0.83	-0.1	-0.89	0.14	0.98	0.19	0.14	0.56

Click cells to compare fundamentals

Impedimed Account Relationship Matchups

Impedimed fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.1M	34.2M	58.7M	68.7M	47.0M	37.4M
Other Current Liab	2.3M	5.6M	3.5M	3.2M	3.2M	3.0M
Total Current Liabilities	5.1M	8.1M	7.2M	5.8M	4.7M	4.8M
Other Liab	87K	398K	413K	864K	993.6K	1.0M
Accounts Payable	1.9M	1.3M	2.6M	1.4M	1.1M	1.4M
Net Receivables	1.7M	2.8M	2.7M	2.6M	2.2M	1.4M
Good Will	2.6M	2.4M	2.6M	2.7M	2.7M	2.5M
Inventory	864K	372K	926K	810K	759K	912.9K
Other Current Assets	3.3M	2.8M	2.3M	2.8M	1.9M	1.7M
Total Liab	5.7M	8.7M	7.7M	7.9M	6.2M	5.2M
Intangible Assets	6.5M	7.5M	11.4M	14.8M	13.3M	14.0M
Common Stock	250.6M	267.3M	307.6M	336.1M	336.1M	185.5M
Property Plant Equipment	1.0M	1.0M	418K	2.0M	2.2M	2.4M
Total Stockholder Equity	27.4M	25.5M	51.0M	60.9M	40.7M	34.4M
Property Plant And Equipment Net	1.0M	1.0M	418K	2.0M	1.4M	1.5M
Net Debt	(18.8M)	(19.2M)	(40.6M)	(44.3M)	(23.5M)	(24.7M)
Retained Earnings	(250.1M)	(270.8M)	(290.6M)	(311.2M)	(331.0M)	(314.4M)
Cash	19.7M	19.7M	40.7M	45.7M	24.6M	28.3M
Non Current Assets Total	7.6M	8.6M	12.0M	16.8M	17.5M	18.4M
Non Currrent Assets Other	(7.6M)	(8.6M)	(11.9M)	(16.8M)	13.3M	14.0M
Cash And Short Term Investments	19.7M	19.7M	40.7M	45.7M	24.6M	28.3M
Common Stock Shares Outstanding	595.2M	1.2B	1.7B	1.8B	2.0B	2.1B
Liabilities And Stockholders Equity	33.1M	34.2M	58.7M	68.7M	47.0M	39.2M
Non Current Liabilities Total	594K	557K	413K	2.0M	1.6M	1.7M
Property Plant And Equipment Gross	1.0M	3.4M	3.8M	5.6M	5.7M	5.9M
Total Current Assets	25.5M	25.7M	46.7M	51.9M	29.5M	32.8M
Accumulated Other Comprehensive Income	26.9M	29.0M	34.1M	36.0M	35.5M	37.3M
Short Term Debt	364K	(562K)	(758K)	141.0K	333K	349.7K
Net Tangible Assets	20.8M	18.1M	39.7M	46.1M	41.5M	28.0M
Current Deferred Revenue	578K	877K	928K	1.0M	1.5M	1.6M
Long Term Investments	77K	73K	75K	78K	54K	62.5K
Net Invested Capital	27.4M	25.5M	51.0M	60.9M	40.7M	43.5M
Cash And Equivalents	8.8M	11.5M	31.3M	13.5M	12.2M	17.0M
Net Working Capital	20.3M	17.5M	39.4M	46.1M	24.8M	24.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Impedimed Stock Analysis

When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC